Tamiko Tamanaha Selected Research

Tamiko Tamanaha Research Topics

Disease

4	Heart Failure 01/2022 - 05/2014
4	Type 2 Diabetes Mellitus (MODY) 11/2020 - 01/2015
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2019 - 01/2015
3	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2015 - 01/2010
2	Dyslipidemias (Dyslipidemia) 10/2019 - 01/2010
2	Hypertension (High Blood Pressure) 10/2019 - 01/2015
2	Homozygous Familial Hypercholesterolemia 08/2019 - 10/2017
2	Atherosclerosis 08/2019 - 10/2017
2	Neoplasms (Cancer) 09/2011 - 08/2009
1	Atrial Fibrillation 01/2022
1	Ventricular Tachycardia 01/2022
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2022
1	Cognitive Dysfunction 11/2020
1	Alzheimer Disease (Alzheimer's Disease) 11/2020
1	Heart Diseases (Heart Disease) 03/2020
1	Left Ventricular Dysfunction 03/2020
1	Obesity 10/2019
1	Glucose Intolerance 10/2019
1	Atherosclerotic Plaque (Atheroma) 10/2019
1	Hypoglycemia (Reactive Hypoglycemia) 10/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2019
1	Peripheral Arterial Disease 10/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015
1	Thyroiditis 03/2014
1	Immunoglobulin G4-Related Disease 03/2014
1	Stroke (Strokes) 11/2013
1	Hyperemia 11/2013
1	Deafness (Deaf Mutism) 01/2013
1	Barakat syndrome 01/2013
1	Hypoparathyroidism 01/2013
1	Hyperaldosteronism (Conn Syndrome) 05/2012
1	Thyroid Neoplasms (Thyroid Cancer) 01/2012
1	Hyperthyroidism 01/2012
1	Goiter 01/2012
1	Adenoma (Adenomas) 01/2012
1	Pituitary ACTH Hypersecretion 09/2011
1	Pituitary Neoplasms (Pituitary Adenoma) 09/2011
1	ACTH-Secreting Pituitary Adenoma 09/2011
1	Hypothyroidism 01/2010
1	Thyrotoxicosis 01/2010
1	Paraganglioma (Paragangliomas) 08/2009

Drug/Important Bio-Agent (IBA)

4	oxidized low density lipoproteinIBA 08/2019 - 01/2015
3	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 10/2019
3	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 10/2019 - 01/2015
3	LDL Lipoproteins (beta Lipoproteins)IBA 08/2019 - 01/2015
2	LipidsIBA 10/2019 - 01/2010
2	SubtilisinIBA 05/2016 - 01/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2015 - 05/2014
2	Nonsense Codon (Nonsense Mutation)IBA 01/2013 - 08/2009
1	PlakophilinsIBA 01/2022
1	Ketone BodiesIBA 03/2020
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 03/2020
1	SodiumIBA 03/2020
1	Indicators and Reagents (Reagents)IBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	HDL LipoproteinsIBA 10/2019
1	Fatty Acid-Binding ProteinsIBA 10/2019
1	Lipoproteins (Lipoprotein)IBA 08/2019
1	Therapeutic UsesIBA 08/2019
1	LinagliptinIBA 04/2019
1	ApolipoproteinsIBA 05/2016
1	LDL Receptors (LDL Receptor)IBA 05/2016
1	anti-thyroglobulinIBA 01/2015
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2015
1	LDL CholesterolIBA 01/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015
1	FurinIBA 01/2015
1	Hemoglobins (Hemoglobin)IBA 05/2014
1	AntibodiesIBA 03/2014
1	Immunoglobulin G (IgG)IBA 03/2014
1	Oral ContraceptivesIBA 11/2013
1	Estrogens (Estrogen)FDA Link 11/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Codon (Codons)IBA 01/2013
1	AldosteroneIBA 05/2012
1	IodineIBA 01/2012
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2012
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2011
1	hydroxide ionIBA 01/2010
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2010
1	Chromogranin AIBA 08/2009

Therapy/Procedure

3	Blood Component Removal (Apheresis) 08/2019 - 01/2015
3	Therapeutics 01/2015 - 01/2010
1	Electric Countershock (Cardioversion) 01/2022
1	Glycemic Control 10/2019